Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 69

Sort by

Sort Order Select

Journal Articles

Cellular and Molecular Characterization of Breast Cancer Chemotherapy-Related B Cell Lymphomas

Madeline Rodriguez Valentin, PhD, Darwing Rivas, BSc, Vesna Jurecic, BSc, Alain Diaz, PhD, Richard Riley, PhD, Daniela Frasca, PhD, Roland Jurecic, PhD

Blood (2019) 134 (Supplement_1): 5241.

https://doi.org/10.1182/blood-2019-127252

Published: 2019

Journal Articles

Homozygosity for -2518 G Allele Variant of MCP-1 Predisposes to Adverse Presentation and Outcome in Primary Myelofibrosis

Elena Masselli, MD, Cecilia Carubbi, PhD, Giulia Pozzi, MS, Antonio Percesepe, MD PhD, Rita Campanelli, Laura Villani, Giuliana Gobbi, PhD, Vittorio Rosti, MD, Margherita Massa, Giovanni Barosi, Marco Vitale, MD

Blood (2019) 134 (Supplement_1): 1689.

https://doi.org/10.1182/blood-2019-122750

Published: 2019

Journal Articles

Elevated Plasma sIL-2Rα Levels in Primary Myelofibrosis Play a Distinct Role on Disease Progression in JAK2V617F and Calr Mutants

Giovanni Barosi, Rita Campanelli, Paolo Catarsi, Mara De Amici, Carlotta Abbà, MSc, Gianluca Viarengo, Laura Villani, Margherita Massa, Vittorio Rosti, MD

Blood (2019) 134 (Supplement_1): 1678.

https://doi.org/10.1182/blood-2019-125531

Published: 2019

Journal Articles

Concomitant BRAF Mutation in Hairy Cell Leukemia and Papillary Thyroid Cancer

Shehab Mohamed, MD, Mohamed A Yassin, MBBS, MSc, Abdulqadir Jeprel Nashwan, BSN, MSN, RN, CBT-HMS, Halima El Omri, Firyal Ibrahim, MB, CHB, PhD, Susana El akiki, PhD

Blood (2018) 132 (Supplement 1): 5140.

https://doi.org/10.1182/blood-2018-99-116084

Published: 2018

Journal Articles

KLF1 Mutations Are Not Common in Israel but Can Explain Occasional Cases of Elevated HbA2 or Very Elevated Fetal Hemoglobin

Deborah Rund, MD, Dvora Filon, PhD, Natalie Bloch Isenberg, MD, Neta Goldschmidt, MD

Blood (2018) 132 (Supplement 1): 3640.

https://doi.org/10.1182/blood-2018-99-113903

Published: 2018

Journal Articles

Synergistic Effect of Imatinib and Ruxolitinib in a Patient with JAK2 V617F positive Myelofibrosis and Concomitant BCR-ABL1 positive Chronic Myeloid Leukemia

Srinivas K. Tantravahi, MBBS, Soo Jin Kim, MS, Jeffrey A Gilreath, PharmD, Anthony D. Pomicter, MS, Tsewang Tashi, MD, Michael W. Deininger, MD PhD, Josef T. Prchal, MD

Blood (2018) 132 (Supplement 1): 5482.

https://doi.org/10.1182/blood-2018-99-119745

Published: 2018

Journal Articles

Atypical Chronic Myeloid Leukemia Challenge in Russian Hematology Practice

Vasily Shuvaev, MD, Karina Krutikova, MD, Svetlana Menshakova, MD, Natalya Kalinova, MD, Irina Martynkevich, MD PhD, Lyubov Polushkina, MD, Elena Belyakova, MD, Yury Krivolapov, MD PhD, Sergei Voloshin, MD PhD

Blood (2018) 132 (Supplement 1): 5483.

https://doi.org/10.1182/blood-2018-99-114885

Published: 2018

Journal Articles

Microenvironment Induced Myelophthisis Caused By CYP26 Deficiency

Laura Palau, MD, Jessica M. Synder, Traci Beth Topping, Cathryn Hogarth, Nina Isoherranen, Gabriel Ghiaur, MD PhD

Blood (2018) 132 (Supplement 1): 1297.

https://doi.org/10.1182/blood-2018-99-115331

Published: 2018

Journal Articles

Idelalisib-Rituximab Results in Considerable Toxicity but Induces Durable Clinical Remissions in Patients with TP53 Disrupted B Cell Prolymphocytic Leukemia

Toby A. Eyre, MBBChir, MRCP, Christopher P. Fox, MBChB, PhD, Ali Boden, MRCP, Adrian Bloor, Moez Dungawalla, Paneesha Shankara, Richard Went, Anna Schuh, MD PhD

Blood (2017) 130 (Supplement 1): 4068.

https://doi.org/10.1182/blood.V130.Suppl_1.4068.4068

Published: 2017

Journal Articles

Dual Deficiency of mDia1 and Mir-146a in an Age-Related Inflammatory Bone Marrow Microenvironment Induces Ineffective Erythropoiesis in Del(5q) MDS

Yang Mei, PhD, Ashley Basiorka, Baobing Zhao, PhD, Jing Yang, Alan F List, MD, Peng Ji, MD PhD

Blood (2016) 128 (22): 3146.

https://doi.org/10.1182/blood.V128.22.3146.3146

Published: 2016

Journal Articles

Symptom Burden As Primary Driver for Therapy in Patients with Myelofibrosis: An Analysis By MPN International Quality of Life Study Group

Robyn M. Scherber, MD MPH, Holly Geyer, MD, Amylou Constance Dueck, PhD, Heidi E. Kosiorek, MS, Jean-Jacques Kiladjian, MD PhD, Stefanie Slot, Sonja Zweegman, MD PhD, Peter Te Boekhorst, Suzan Commandeur, MSc, Harry C. Schouten, Federico Sackmann, MD, Ana Kerguelen Fuentes, MD, Dolores Hernandez-Maraver, PhD, Heike L Pahl, PhD, Martin Griesshammer, MD, Frank Stegelmann, MD, Konstanze Doehner, MD, Thomas Lehmann, Karen Bonatz, Andreas Reiter, MD, Francoise Boyer, MD, Gabriel Etienne, MD PhD, Jean Christophe Ianotto, Dana Ranta, MD, Lydia Roy, MD, Jean-Yves Cahn, MD, Claire N. Harrison, DM, FRCP, FRCPath, Deepti Radia, MBBS, MRCPI, FRCPath MSc, MD, Pablo J. Muxi, MD, Norman I Maldonado, MD, Carlos Besses, MD PhD, Francisco Cervantes, MD PhD, Peter L. Johansson, MD PhD, Tiziano Barbui, MD, Giovanni Barosi, Alessandro M. Vannucchi, MD, Bjorn Andreasson, Maria Ferarri, Alessandro Rambaldi, MD, Jan Samuelsson, MD PhD, Gunnar Birgegard, MD PhD, Keith Cannon, MD, Xuijuan Sun, Junqing Xu, Peihong Zhang, Zefeng Xu, Ruben A. Mesa, MD

Blood (2016) 128 (22): 3117.

https://doi.org/10.1182/blood.V128.22.3117.3117

Published: 2016

Journal Articles

Comprehensive Biological and Molecular Characterization of a RARE Case of Cutaneous Richter Syndrome

Ramona Cassin, MD, Gianluigi Reda, MD, Sonia Fabris, BSc, Nicola Orofino, MD, Bruno Fattizzo, MD, Umberto Gianelli, MD, Antonino Neri, Pr, MD, Agostino Cortelezzi, MD

Blood (2015) 126 (23): 5281.

https://doi.org/10.1182/blood.V126.23.5281.5281

Published: 2015

Journal Articles

The Role of Spleen Directed Therapy and Predictors of Outcomes with Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Primary Myelofibrosis and Splenomegaly

Daniel K. Partain, MD, Moussab Damlaj, MD, Aref Al-Kali, MD, Naseema Gangat, MBBS, Mark R Litzow, MD, William J Hogan, MBChB, Shahrukh K. Hashmi, MD, Wilson I. Gonsalves, MD, James M. Foran, MD, Vivek Roy, MD FACP, Ruben A. Mesa, Jeanne Palmer, MD, James L. Slack, MD, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 4370.

https://doi.org/10.1182/blood.V126.23.4370.4370

Published: 2015

Journal Articles

Risk Factors for Infections in Myelofibrosis: Role of Disease Status and Treatment. A Study on 507 Patients

Nicola Polverelli, MD, Massimo Breccia, MD, Giulia Benevolo, MD, Bruno Martino, MD, Alessia Tieghi, MD, Roberto Latagliata, MD, Lucia Catani, PhD, Maura Nicolosi, MD, Margherita Perricone, Marco Romano, Gioia Colafigli, Anna Campana, Francesco Merli, MD, Umberto Vitolo, Giuliana Alimena, MD, Giovanni Martinelli, Michele Cavo, MD, Nicola Vianelli, MD, Francesca Palandri, MD PhD

Blood (2015) 126 (23): 1606.

https://doi.org/10.1182/blood.V126.23.1606.1606

Published: 2015

Journal Articles

The Assessment of the European Leukemianet Criteria for Clinicohematologic Resistance and Intolerance to Hydroxyurea in Polycythemia Vera Is Not Easily Applicable in Daily Practice

Laura Fogliatto, MD, Raquel Breunig, MD, Tito Vanelli Costa, MD, Luis Carlos Zanandrea Contin, MD, Juarez Fontoura Silveira, Cinara Silveira, Liane Esteves Daudt, MD PhD, Lucia Silla, MD PhD

Blood (2014) 124 (21): 5550.

https://doi.org/10.1182/blood.V124.21.5550.5550

Published: 2014

Journal Articles

Myeloproliferative Disease and Myeloid Leukemia in Dnmt3a Haploinsufficient Mice

Christopher B Cole, Angela M. Verdoni, PhD, Gue Su Chang, PhD, Chris Miller, PhD, Timothy J. Ley, MD

Blood (2014) 124 (21): 890.

https://doi.org/10.1182/blood.V124.21.890.890

Published: 2014

Journal Articles

Multicentric Bone Involvement As Presentation Of Late Relapse In a Patient With Hairy Cell Leukemia (HCL)

Joyce E Hyppolito, Guilherme Fleury Perini, MD, Paulo Vidal Campregher, MD, Denise da cunha Pasqualin, MD, Reynaldo Jesus Garcia Filho, MD, Nelson Hamerschlak, MD, PhD

Blood (2013) 122 (21): 5285.

https://doi.org/10.1182/blood.V122.21.5285.5285

Published: 2013

Journal Articles

Neutropenia In Glycogen Storage Disease 1b (GSD1b)

David C. Dale, MD, Audrey Anna Bolyard, RN, BS, Tracy M. Marrero, Merideth L. Kelley, MS, BS, Lan Phan, BA, Laurence A. Boxer, MD, Priya S. Kishnani, MD, MB, Joanne Kurtzberg, MD, David A. Weinstein, MD, MMSc

Blood (2013) 122 (21): 2265.

https://doi.org/10.1182/blood.V122.21.2265.2265

Published: 2013

Journal Articles

Significant Improvement In Quality Of Life (QoL) In Patients With Chronic Myeloproliferative Neoplasms and Myelofibrosis Treated With JAK-1 and JAK-2 Inhibitor Ruxolitinib. A Single Institution Experience In Mexico

Pablo Vargas-Viveros, MD, Rafael Hurtado Monroy, MD, Myrna Candelaria-Hernandez, MD

Blood (2013) 122 (21): 5252.

https://doi.org/10.1182/blood.V122.21.5252.5252

Published: 2013

Journal Articles

Familial Mastocytosis: Identification Of KIT K509I Mutation and Its In Vitro Sensitivity To Imatinib, Dasatinib and PKC412

Paula De Melo Campos, MD, João Agostinho Machado-Neto, MSc, Adriana Silva Santos Duarte, PhD, Renata Scopim-Ribeiro, BSc, Flavia Fonseca de Carvalho Barra, MD, José Vassallo, MD, PhD, Irene Lorand-Metze, MD, PhD, Ramon V. Tiu, MD, Fernando Ferreira Costa, MD, PhD, Sara T O Saad, MD, PhD, Fabiola Traina, M.D., Ph.D.

Blood (2013) 122 (21): 5267.

https://doi.org/10.1182/blood.V122.21.5267.5267

Published: 2013

NARROW

Cellular and Molecular Characterization of Breast Cancer Chemotherapy-Related B Cell Lymphomas

Homozygosity for -2518 G Allele Variant of MCP-1 Predisposes to Adverse Presentation and Outcome in Primary Myelofibrosis

Elevated Plasma sIL-2Rα Levels in Primary Myelofibrosis Play a Distinct Role on Disease Progression in JAK2V617F and Calr Mutants

Concomitant BRAF Mutation in Hairy Cell Leukemia and Papillary Thyroid Cancer

KLF1 Mutations Are Not Common in Israel but Can Explain Occasional Cases of Elevated HbA2 or Very Elevated Fetal Hemoglobin

Synergistic Effect of Imatinib and Ruxolitinib in a Patient with JAK2 V617F positive Myelofibrosis and Concomitant BCR-ABL1 positive Chronic Myeloid Leukemia

Atypical Chronic Myeloid Leukemia Challenge in Russian Hematology Practice

Microenvironment Induced Myelophthisis Caused By CYP26 Deficiency

Idelalisib-Rituximab Results in Considerable Toxicity but Induces Durable Clinical Remissions in Patients with TP53 Disrupted B Cell Prolymphocytic Leukemia

Dual Deficiency of mDia1 and Mir-146a in an Age-Related Inflammatory Bone Marrow Microenvironment Induces Ineffective Erythropoiesis in Del(5q) MDS

Symptom Burden As Primary Driver for Therapy in Patients with Myelofibrosis: An Analysis By MPN International Quality of Life Study Group

Comprehensive Biological and Molecular Characterization of a RARE Case of Cutaneous Richter Syndrome

The Role of Spleen Directed Therapy and Predictors of Outcomes with Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Primary Myelofibrosis and Splenomegaly

Risk Factors for Infections in Myelofibrosis: Role of Disease Status and Treatment. A Study on 507 Patients

The Assessment of the European Leukemianet Criteria for Clinicohematologic Resistance and Intolerance to Hydroxyurea in Polycythemia Vera Is Not Easily Applicable in Daily Practice

Myeloproliferative Disease and Myeloid Leukemia in Dnmt3a Haploinsufficient Mice

Multicentric Bone Involvement As Presentation Of Late Relapse In a Patient With Hairy Cell Leukemia (HCL)

Neutropenia In Glycogen Storage Disease 1b (GSD1b)

Significant Improvement In Quality Of Life (QoL) In Patients With Chronic Myeloproliferative Neoplasms and Myelofibrosis Treated With JAK-1 and JAK-2 Inhibitor Ruxolitinib. A Single Institution Experience In Mexico

Familial Mastocytosis: Identification Of KIT K509I Mutation and Its In Vitro Sensitivity To Imatinib, Dasatinib and PKC412

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only